Sergio Barragan-Duran

Guadalajara, JAL, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.

Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.

Journal: The New England journal of medicine

Published: June 03, 2026

Response to the letter to the editor: "Latent tuberculosis in rheumatologic patients under biological therapy: Methodological considerations and a primary care perspective".

Response to the letter to the editor: "Latent tuberculosis in rheumatologic patients under biological therapy: Methodological considerations and a primary care perspective".

Journal: Reumatologia clinica

Published: May 05, 2026

Differential glomerular expression patterns of Th17-related cytokines in Mexican patients with lupus nephritis.

Differential glomerular expression patterns of Th17-related cytokines in Mexican patients with lupus nephritis.

Journal: Lupus

Published: November 27, 2025

Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registry.

Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registry.

Journal: Reumatologia clinica

Published: August 01, 2025

Differences in Clinical Profiles and Biologic Treatment Approaches for Autoimmune Rheumatic Diseases Across Regions in Mexico: An Analysis of the BIOBADAMEX Cohort.

Differences in Clinical Profiles and Biologic Treatment Approaches for Autoimmune Rheumatic Diseases Across Regions in Mexico: An Analysis of the BIOBADAMEX Cohort.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: January 06, 2025

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Journal: Reumatologia clinica

Published: June 21, 2024

High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.

High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: May 16, 2024

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.

Journal: Reumatologia clinica

Published: January 25, 2024

Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients.

Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients.

Journal: Lupus

Published: August 29, 2022

Impaired muscle strength is associated with ultrastructure damage in myositis.

Impaired muscle strength is associated with ultrastructure damage in myositis.

Journal: Scientific reports

Published: May 18, 2022

Going Further: Comprehensive Disease Control of Rheumatoid Arthritis, Targeting Cytokines and Chemokines.

Going Further: Comprehensive Disease Control of Rheumatoid Arthritis, Targeting Cytokines and Chemokines.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: July 23, 2020

Enalapril Influence on Arterial Stiffness in Rheumatoid Arthritis Women: A Randomized Clinical Trial.

Enalapril Influence on Arterial Stiffness in Rheumatoid Arthritis Women: A Randomized Clinical Trial.

Journal: Frontiers in medicine

Published: September 13, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026